|
- Mayo Clinics AI tool identifies 9 dementia types, including Alzheimer . . .
Mayo Clinic researchers have developed a new artificial intelligence tool that helps clinicians identify nine types of dementia
- Moments of clarity in the fog of dementia - Mayo Clinic News Network
The Journal of the Alzheimer's Association investigated lucid episodes in people living with later stages of dementia Learn more
- What is frontotemporal dementia? - Mayo Clinic News Network
Frontotemporal degeneration (FTD) is a group of neurologic disorders associated with changes in personality, behavior, language or movement
- Mayo Clinic contributes to national Alzheimers disease research . . .
A new report identifies national research priorities for Alzheimer's disease and related dementias over the next decade
- Mayo Clinic Q and A: Lewy body dementia and Alzheimer’s disease — what . . .
In Lewy body dementia, Lewy bodies are found in the deep structures of the brain that control movement, as well as in the middle and outer structures involved in emotion, behavior, judgment and awareness Many patients with Lewy body dementia also have overlapping Alzheimer’s disease
- Mayo Clinic Minute: What is vascular dementia?
An estimated 55 million people are believed to be living with dementia, according to health officials Vascular diseases contribute to approximately 25% of all diagnoses When blood vessels are damaged or blocked, it can deprive your brain of vital oxygen and nutrients, which could lead to a condition called vascular dementia Watch: The Mayo Clinic Minute Journalists: Broadcast-quality video
- Researchers identify new criteria to detect rapidly progressive dementia
Mayo Clinic researchers have identified new scoring criteria allowing for the detection of treatable forms of rapidly progressive dementia
- Mayo Clinic researchers validate blood test to diagnose Alzheimers . . .
They included patients with early- and late-onset cognitive impairment, typical and atypical Alzheimer's disease, Lewy body dementia and vascular cognitive impairment Patients ranged from 32 to 89 years old, with the average age of symptom onset being 66
|
|
|